Redeye Feed

2025-05-08 13:53:00 Xspray Pharma Q1 2025 - All eyes on PDUFA

2025-05-08 13:52:00 Invisio - Soft Q1, but outlook remains strong

2025-05-08 13:51:00 G5 Entertainment - Growth setback, but potential for improvement in H2

2025-05-08 13:50:00 Cheffelo - Kickstarting the year

2025-05-08 13:49:00 Avensia - Strong performance in a cautious market

2025-05-08 13:48:00 CombinedX - Room for digitalisation

2025-05-08 07:31:00 AroCell Q1 - Solid but undetected

2025-05-08 07:30:00 Cheffelo - Kickstarting the year

2025-05-08 07:29:00 Avensia - Strong performance in a cautious market

2025-05-08 07:25:00 CombinedX - Room for digitalisation

2025-05-07 14:21:00 AlzeCure Q1 2025 - Momentum from the get-go

2025-05-07 12:14:00 OssDsign Q1 - … and a strong quarter to start the year

2025-05-07 12:12:00 Freemelt - Expecting a record quarter

2025-05-07 12:11:00 Scandinavian ChemoTech - Momentum continues

2025-05-07 12:11:00 Bredband2 - Q1 Review – Geared for Growth

2025-05-07 11:58:00 CTEK - Another strong quarter and a potentially exciting CMD awaits in May

2025-05-07 11:57:00 Acconeer - Making 2026 Sense-ational

2025-05-07 11:56:00 Optomed Q1 - A solid start to the year

2025-05-07 11:55:00 Teneo AI - Bump on the road

2025-05-07 11:54:00 Hanza - Extended focus on growth segments

2025-05-06 17:28:00 Mendus Q1 2025 - Decent progress

2025-05-06 11:21:00 Absolent - Major airpocket

2025-05-06 11:04:00 Physitrack - Solid start to 2025 with improving margins

2025-05-06 11:03:00 Cellavision Q1 2025 - EMEA Drove Sales Growth

2025-05-05 13:53:00 Modelon - Improving core metrics amidst soft short-term outlook

2025-05-05 13:35:00 OXE Marine - Promising start to 2025

2025-05-05 11:55:00 Redeye initiates coverage of Indutrade

2025-05-02 14:51:00 BrightBid Q1 2025 prel - Soft preliminary ARR – further cost-savings

2025-05-02 14:50:00 Egetis Therapeutics Q1 - Emcitate is now launched in Germany

2025-05-02 14:46:00 Ependion - Blended picture

2025-05-02 14:46:00 Evolution - Regulatory headwind hits growth in Europe

2025-05-02 14:45:00 Momentum Group - Continued strong M&A execution

2025-05-02 14:43:00 Gapwaves - Wave of positive news flow expected

2025-05-02 14:42:00 Arise - Positioned for high activity in H2 2025

2025-05-02 14:41:00 Hexatronic - Increased uncertainty hurting forecasts

2025-05-02 14:40:00 Formpipe - A solid step towards the 2025 margin target

2025-04-30 13:26:00 BioInvent Q1 2025 - Focus on BI-1808 in T-cell Lymphoma

2025-04-30 08:25:00 Devyser Q1 - A most exciting year

2025-04-30 08:04:00 SSH Communications Security - Soft quarter but sales should improve throughout the year

2025-04-30 07:54:00 M.O.B.A. Network - Expected rebound likely postponed

2025-04-30 07:52:00 Medivir Q1 2025 - Calm Quarter Awaiting Phase IIb

2025-04-30 07:50:00 Sdiptech - Brighter times ahead

2025-04-30 07:49:00 Tradedoubler - Something new on the Western front

2025-04-30 07:47:00 MedCap Q1 2025 - Step by step

2025-04-30 07:45:00 Serstech - Adjusting the lens

2025-04-29 09:12:00 Curasight Q1 - Securing runway to readouts

2025-04-29 09:11:00 Hansa Biopharma update - The European launch regains momentum

2025-04-29 09:06:00 NextCell Pharma Q2 2024/2025 - No cow on the ice

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Redeye

Prenumeration

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden